▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

GoodRx (NASDAQ: GDRX)

$3.96

(0.1%)

$0.00

Price as of May 20, 2025, 3:35 p.m. ET

GoodRx Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
GDRX	-47.19%			-92%
S&P	+12.45%	+100.69%	+14.95%	+84%

GoodRx Company Info

GoodRx Holdings, Inc. engages in the business of a consumer-focused digital healthcare platform. The firm offers consumers free access to transparent and lower prices for brand and generic medications, affordable and convenient medical provider consultations via telehealth, and comprehensive healthcare research and information. The company was founded by Trevor Bezdek and Douglas Joseph Hirsch in September 2015 and is headquartered in Santa Monica, CA.

News & Analysis

The Fool has written over 100 articles on GoodRx.

Featured Article

Why GoodRx Holdings Stock Triumphed on Thursday

Eric Volkman | May 8, 2025

Featured Article

Why GoodRx Holdings Stock Was Sinking This Week

The company is growing key fundamentals. However, the improvements weren't enough to impress the market.

Eric Volkman | Nov 8, 2024

Investing in Telemedicine and Telehealth Stocks

Keith Speights | Oct 14, 2024

Why GoodRx Surged Today

Billy Duberstein | Mar 25, 2024

The prescription-drug upstart got an upgrade from Wall Street.

Why GoodRx Stock Soared Today

Steve Symington | Feb 29, 2024

The company beat Q4 estimates, announced a new share repurchase authorization, and issued strong guidance.

Why GoodRx Holdings Stock Dived by Nearly 19% Today

Eric Volkman | Nov 9, 2023

An unimpressive quarter featuring weak guidance led investors to hit the sell button.

Why Shares of GoodRx Holdings Climbed This Week

Jim Halley | Jul 13, 2023

The company agreed to a plan that will use its prescription pricing to help CVS Caremark members.

Why Shares of GoodRx Holdings Fell This Week

Jim Halley | Apr 28, 2023

The company announced a C-suite shakeup earlier in the week.

Valuation

Podcast Episodes

cover_IF

A Look at GoodRx, Inari, and Amwell

How have these big healthcare IPOs been doing?

Brian Feroldi | Feb 20, 2021

cover_IF

Why You Must Have GoodRx on Your Watch List

It brings transparency to prescription pricing, generating $20 billion in consumer savings.

Brian Feroldi | Sep 28, 2020

Earnings Transcripts

GoodRx (GDRX) Q4 2024 Earnings Call Transcript

GDRX earnings call for the period ending December 31, 2024.

Motley Fool Transcribing | Feb 27, 2025

GoodRx (GDRX) Q3 2024 Earnings Call Transcript

GDRX earnings call for the period ending September 30, 2024.

Motley Fool Transcribing | Nov 7, 2024

GoodRx (GDRX) Q2 2024 Earnings Call Transcript

GDRX earnings call for the period ending June 30, 2024.

Motley Fool Transcribing | Aug 8, 2024

GoodRx (GDRX) Q1 2024 Earnings Call Transcript

GDRX earnings call for the period ending March 31, 2024.

Motley Fool Transcribing | May 9, 2024

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services